RxDoctor Payments Data

Clayton Lowder, MD

Family Medicine · Sumter, SCNPI 1184671075

Payments from drug & device makers

$3,955in general payments, 2019–2025

Across 263 payments — averaging $15.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$862
  • Novo Nordisk$433
  • AstraZeneca$225
  • Astellas Pharma US Inc$211
  • Takeda Pharmaceuticals U.S.A., Inc.$187
  • Pfizer$156
  • plus $2K from 36 others

What the payments were for

  • Food & beverage$3,74295%
  • Education$2135%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,955 in reported general payments places this provider in the 80th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$325,368
Medicare patients
316
Services billed
14,625

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide272$298,028
JanuviaSitagliptin Phosphate128$95,169
EliquisApixaban124$80,684
Trelegy ElliptaFluticasone/Umeclidin/Vilanter86$69,005
XareltoRivaroxaban82$62,645
OzempicSemaglutide53$62,535
JardianceEmpagliflozin78$52,915
LinzessLinaclotide52$45,963
FarxigaDapagliflozin Propanediol47$30,929
Nurtec OdtRimegepant Sulfate11$22,492
MyrbetriqMirabegron27$17,234
Fluticasone-SalmeterolFluticasone Propion/Salmeterol118$16,922
Spiriva RespimatTiotropium Bromide30$15,007
KerendiaFinerenone19$14,822
EntrestoSacubitril/Valsartan21$14,134

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$46$310,270285 claims
PfizerEliquis, Nurtec Odt, Premarin$156$108,743153 claims
MerckJanuvia$25$95,169128 claims
GSKTrelegy Ellipta, Anoro Ellipta$77$74,22698 claims
Boehringer IngelheimJardiance, Spiriva Respimat$67$67,922108 claims
Johnson & JohnsonXarelto$147$62,64582 claims
Novo NordiskOzempic$433$62,53553 claims
AbbVieLinzess$862$45,96352 claims
AstraZenecaFarxiga, Brilinta$225$41,51771 claims
Astellas Pharma US IncMyrbetriq$211$17,23427 claims
BayerKerendia$109$14,82219 claims
NovartisEntresto$60$14,13421 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Sumter

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →